Some of the major precision Medicine market players are Tepnel Pharma Services, Biocrates Life Sciences, Qiagen, Novartis, NanoString Technologies, Menarini Silicon Biosystems, Pfizer, Eagle Genomics, Roche, Intomics, Quest Diagnostics, and Teva Pharmaceutical.

The North American precision medicine market value surpassed USD 21 billion in 2018 and is set to achieve 9%+ CAGR from 2019 to 2025, on account of favorable government scenario coupled with increased funding for research in precision medicine.